Key Findings

We examined the behaviors, attitudes, and expectations around COVID of consumers from 18 countries. Highlights from this study include:

  • Online activities grew in popularity in all countries… 77% of all respondents reported starting at least one of 11 online activities since the onset of the COVID-19 pandemic.
  • …But the growth may not be sustained. Depending on the online activity and the country, some consumers expect to curtail their online behaviors after the pandemic is over. Indian consumers expect to continue with their current online behaviors at the highest rates, while Japanese consumers expect to continue at the lowest rates.
  • Many consumers remain vaccine hesitant. More than one-third of consumers said they were not yet planning to get the vaccine when it becomes available to them, with potential side effects and safety concerns cited most frequently as the given reasons.
  • Consumers are not satisfied with their governments’ approach the the vaccine. Fewer than half of consumers said they felt satisfied with their government’s communications around vaccine effectiveness, their communications around the vaccination process, or the process for scheduling vaccinations. Consumers in France, Germany, and Japan were least satisfied with their government’s approach to vaccination.

Figures

Here are the figures in this Data Snapshot:

  1. New Participation in Online Activities – Overall
  2. New Participation in Online Activities by Country (Part 1)
  3. New Participation in Online Activities by Country (Part 2)
  4. Participation in Online Activities Post-Pandemic – Overall
  5. Participation in Online Activities Post-Pandemic by Country (Part 1)
  6. Participation in Online Activities Post-Pandemic by Country (Part 2)
  7. Expectations for Returning to Normal by Country
  8. Plans for COVID Vaccination – Overall
  9. Plans for COVID Vaccination by Country (Part 1)
  10. Plans for COVID Vaccination by Country (Part 2)
  11. Communication about COVID Vaccines – Overall
  12. Communication about COVID Vaccines by Country
  13. Methodology